Lördag 21 December | 18:44:26 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2025-02-27 08:00 Bokslutskommuniké 2024
2024-12-05 - Split POLAR 300:1
2024-11-29 - Kvartalsrapport 2024-Q3
2024-11-19 - Extra Bolagsstämma 2024
2024-08-30 - Kvartalsrapport 2024-Q2
2024-05-31 - Kvartalsrapport 2024-Q1
2024-05-29 - X-dag ordinarie utdelning POLAR 0.00 SEK
2024-05-28 - Årsstämma
2024-02-23 - Bokslutskommuniké 2023
2023-11-24 - Kvartalsrapport 2023-Q3
2023-09-08 - Extra Bolagsstämma 2023
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-26 - Kvartalsrapport 2023-Q1
2023-05-17 - Årsstämma
2023-05-05 - X-dag ordinarie utdelning POLAR 0.00 SEK
2023-03-13 - Extra Bolagsstämma 2022
2023-02-24 - Bokslutskommuniké 2022
2022-11-25 - Kvartalsrapport 2022-Q3
2022-08-26 - Kvartalsrapport 2022-Q2
2022-05-27 - Kvartalsrapport 2022-Q1
2022-05-06 - X-dag ordinarie utdelning POLAR 0.00 SEK
2022-05-05 - Årsstämma
2022-02-25 - Bokslutskommuniké 2021
2021-11-26 - Kvartalsrapport 2021-Q3
2021-08-27 - Kvartalsrapport 2021-Q2
2021-05-28 - Kvartalsrapport 2021-Q1
2021-05-06 - X-dag ordinarie utdelning POLAR 0.00 SEK
2021-05-05 - Årsstämma
2021-02-26 - Bokslutskommuniké 2020
2020-11-27 - Kvartalsrapport 2020-Q3
2020-08-28 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning POLAR 0.00 SEK
2020-06-30 - Årsstämma
2020-05-29 - Kvartalsrapport 2020-Q1
2020-02-28 - Bokslutskommuniké 2019
2020-02-14 - Extra Bolagsstämma 2020
2019-10-23 - Kvartalsrapport 2019-Q3
2019-07-24 - Kvartalsrapport 2019-Q2
2019-05-07 - Split POLAR 16:1
2019-04-26 - Kvartalsrapport 2019-Q1
2019-03-19 - Årsstämma
2019-02-04 - X-dag ordinarie utdelning POLAR 0.00 SEK
2019-02-01 - Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Polarcool är verksamt inom medicinteknik. Idag är bolaget inriktade mot att produkter och lösningar inriktade för skador inom sport och aktivitet. Störst fokus återfinns inom forskning och utveckling av produkter som används vid behandling av hjärnskador vid exempelvis boxning, rugby och amerikansk fotboll. Verksamhet innehas på global nivå, med störst närvaro inom den europeiska marknaden.
2024-12-03 10:01:00

The Med-Tech company PolarCool AB (publ.) continues its expansion in German ice hockey, securing a two-year agreement with EC Red Bull München. This partnership further solidifies PolarCap's presences in Germany's top league (DEL), where 9 out of 14 ice hockey clubs now provide the PolarCap® System.

The agreement with Red Bull München represents continued progress for PolarCool in the German ice hockey market. In DEL, Germany's top league, Red Bull München joins a number of clubs in the league already providing PolarCap®. At present Adler Mannheim, Eisbären Berlin, Straubing Tigers, Kölner Haie, Augsburger Panther, Schwenninger Wild Wings, Iserlohn Roosters, and Nürnberg Ice Tigers have implemented PolarCap® into their concussion management routines.

PolarCool recently signed its first agreement with a Red Bull group team, as Austrian ice hockey team Red Bull Salzburg became a provider. Beyond its two ice hockey teams, Red Bull owns five professional football teams across Europe and is a prominent force in motorsports and extreme sports, where concussions are also a significant concern.

PolarCool CEO Erik Andersson comments:

-Signing another agreement with a Red Bull ice hockey team is highly gratifying. Our foothold in the ice hockey market continues to strengthen. We look forward to further developing our partnership with the Red Bull group as well as increasing our presence in European ice hockey.  

PolarCool sees continued potential in the German ice hockey market, and is actively engaged in discussions with other teams in DEL and DEL2. Combined, the two top leagues encompass 28 teams. While the financial impact of individual agreements is limited, the agreement with Red Bull München holds strategic importance.